Boston Scientific Corp. has moved up to the 10th position in aggregated analyst rankings for S&P 500 components. The company's stock has seen a substantial year-to-date increase of 45.5%.
- Ranked #10 among S&P 500 components
- Moved up one spot in analyst preference
- YTD stock price gain of 45.5%
- Ranking based on average brokerage opinions
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.